Levy Adam D. insider trades
Levy Adam D. has filed 6 Form 4s with the SEC that we hold, all for Acrivon Therapeutics, Inc. (ACRV), as Chief Financial Officer. Across all of them we count 1 purchase worth $15.0K and 1 sale worth $1.8K reported on Form 4. In the last 12 months: 1 purchase ($15.0K) and 1 sale ($1.8K). The largest single trade was a purchase of 8,832 shares of Acrivon Therapeutics, Inc. worth $15.0K, dated 2026-01-14. The first filing on our record is dated 2025-04-03 and the latest 2026-08-06.
Acrivon Therapeutics, Inc. (ACRV)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-01-14 | P, purchase reported on Form 4 | 8,832 | $15.0K | 2026-01-16 |
| 2026-08-04 | S, sale reported on Form 4 | 1,142 | $1.8K | 2026-08-06 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2061876) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms